Healthcare help desk outsourcing costs in 2026

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Healthcare help desk outsourcing costs range from $50 to $150 per user each month for full HIPAA-compliant coverage. Depending on the region, it ranges from $8 to $60 per hour. Compliance and EHR expertise drive the premium over standard IT support. This guide breaks down pricing models, per-ticket rates, EHR support, and the in-house comparison. […]

The post Healthcare help desk outsourcing costs in 2026 appeared first on Medical News Bulletin.

Bulletin: IVF Add-ons an Expensive Waste of time?

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Top infertility doctors reported in the Lancet obstetrics, gynaecology & women’s health yesterday that many of the ‘add-ons’ suggested by IVF clinics don’t help couples to achieve a full-term pregnancy. Right now the average success rate of a cycle of IVF is 30–40%. Clinics routinely offer ‘add-on’ treatments that they say will increase a couple’s […]

The post Bulletin: IVF Add-ons an Expensive Waste of time? appeared first on Medical News Bulletin.

How Licensed Peptides Approaches Quality Assurance in the Research Materials Market

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Quality assurance isn’t really the first thing people discuss when they’re evaluating research materials. Product availability and delivery times tend to dominate the conversation, along with pricing structures. Yet for many laboratories and experienced purchasers, the real difference often sits behind the product itself: documentation. A product label can make a variety of claims. What […]

The post How Licensed Peptides Approaches Quality Assurance in the Research Materials Market appeared first on Medical News Bulletin.

FDA OKs Ibrance in HR-positive, HER2-positive breast cancer

The FDA has approved the first and only cyclin-dependent kinase 4/6 inhibitor for patients with HR-positive metastatic breast cancer, regardless of HER2 status.
Palbociclib (Ibrance, Pfizer) was approved in combination with trastuzumab (Herceptin, Genentech), with or without pertuzumab (Perjeta, Genetech), and endocrine therapy as maintenance treatment for adults with HR-positive, HER2-positive locally advanced or metastatic breast cancer after induction.
“Resistance to dual anti-HER2 and endocrine therapy remains a central clinical challenge for patients with HR-positive, HER2-positive

Over half of Americans unable to afford health care if needed

A record number of Americans are unable to consistently afford health care visits and medications if they need them, according to a new West Health and Gallup report.
The findings indicate that “affordability challenges are becoming more widespread,” and “insurance coverage alone does not guarantee affordability,” as many Americans continue to face high deductibles, copayments, coinsurance and prescription drug costs, Zia Agha, MD, chief medical officer at West Health Institute, told Healio.
“Health care affordability is moving in the wrong direction,” Agha said. “Notably, financial barriers

FDA advisors back approval of mRNA flu shot

An FDA advisory committee voted unanimously on June 18 to recommend that a messenger RNA-based influenza vaccine at the center of a recent change of heart by the FDA be approved for older adults.
In two 9-0 votes, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) declared that the benefits of mRNA-1010 (mFlusiva, Moderna) outweigh the risks for adults aged 50 through 64 years and 65 years or older.
The FDA will consider the panel’s recommendation when it makes a final decision on the vaccine, which is expected by Aug. 5. If approved, it would be the world’s first

Autoimmune disease patients on Xiidra have aqueous tear deficiency

PHOENIX — In patients with autoimmune disease prescribed Xiidra, the most common form of dry eye disease was aqueous tear deficiency, and cataracts were common, according to a study presented at Optometry’s Meeting.
“The goal was to begin to help providers identify patient types that this medication is commonly used for,” study author Shane R. Kannarr, OD, of Kannarr Eye Care in Pittsburg, Kansas, told Healio. “In turn, this will allow providers to develop commonly accepted treatment protocols.”
Kannarr retrospectively analyzed the characteristics of 143,005 patients with dry eye disease who

Millions of women overdue for common cancer screenings

Nearly 18 million women in the U.S. aged 45 to 64 years are likely overdue for breast, cervical or colorectal cancer screenings, and more than 3 million are estimated to not be up to date on all three.
Survey data from 68,000 women showed that having annual wellness visits and a regular health care provider significantly increased the likelihood of being up to date with at least one, as well as all screenings. Greater educational attainment and being insured also were associated with higher screening uptake.
However, interventions targeting multiple screenings could be beneficial, as only 50%

Omega-3 supplements not silver bullet for dementia

Omega-3 fatty acids may not deliver benefits for cognitive function on their own, according to a study published in eBioMedicine.
The results show the need for a multimodal approach to preventing dementia in older adults, one that simultaneously addresses physical inactivity, vascular health and other risk factors, Hussein Yassine, MD, director of the USC Center for Personalized Brain Health, and colleagues wrote.
“Previous research has shown a link between lower levels of omega-3s and higher risk of dementia,” Yassine told Healio.
Yassine and colleagues designed the trial with an interest in

Blood pressure control major barrier in women’s heart health

PHILADELPHIA — Women may have higher risk for heart disease related to elevated blood pressure compared with men, yet only one in four with hypertension have their BP under control, a speaker reported.
At the Heart in Diabetes CME Conference, Healio | Cardiology Today Editorial Board Member Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC, director of women’s cardiovascular health at Johns Hopkins School of Medicine, discussed how women’s BP can be affected by reproductive health and why it’s important to monitor BP throughout their life course.
“Before midlife, women actually have lower BP